Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$3.64 - $7.78 $57,286 - $122,441
-15,738 Closed
0 $0
Q3 2021

May 17, 2024

BUY
$6.01 - $8.71 $75,317 - $109,153
12,532 Added 390.89%
15,738 $123,000
Q3 2021

Jun 21, 2023

BUY
$6.01 - $8.71 $94,585 - $137,077
15,738 New
15,738 $123,000
Q3 2021

Mar 22, 2023

BUY
$6.01 - $8.71 $75,317 - $109,153
12,532 Added 390.89%
15,738 $123,000
Q3 2021

Nov 15, 2021

BUY
$6.01 - $8.71 $94,585 - $137,077
15,738 New
15,738 $124,000
Q2 2021

Aug 16, 2021

SELL
$6.02 - $9.64 $19,300 - $30,905
-3,206 Closed
0 $0
Q1 2021

May 17, 2024

BUY
$9.17 - $14.8 $29,399 - $47,448
3,206 New
3,206 $30,000
Q1 2021

Jun 26, 2023

BUY
$9.17 - $14.8 $29,399 - $47,448
3,206 New
3,206 $30.2 Million
Q1 2021

Mar 22, 2023

SELL
$9.17 - $14.8 $116,578 - $188,152
-12,713 Reduced 79.86%
3,206 $30,000
Q1 2021

May 14, 2021

SELL
$9.17 - $14.8 $116,578 - $188,152
-12,713 Reduced 79.86%
3,206 $30,000
Q4 2020

Jun 22, 2023

BUY
$8.92 - $13.29 $141,997 - $211,563
15,919 New
15,919 $179,000
Q3 2020

Jun 26, 2023

BUY
$9.94 - $16.59 $158,234 - $264,096
15,919 New
15,919 $170,000
Q2 2020

May 24, 2024

BUY
$12.07 - $19.34 $192,142 - $307,873
15,919 New
15,919 $242 Million
Q2 2020

Jun 26, 2023

BUY
$12.07 - $19.34 $192,142 - $307,873
15,919 New
15,919 $241,000
Q2 2020

Mar 22, 2023

BUY
$12.07 - $19.34 $47,471 - $76,064
3,933 Added 32.81%
15,919 $241,000
Q2 2020

Aug 14, 2020

BUY
$12.07 - $19.34 $47,471 - $76,064
3,933 Added 32.81%
15,919 $242,000
Q1 2020

Jul 12, 2023

BUY
$12.5 - $22.04 $149,825 - $264,171
11,986 New
11,986 $186,000
Q4 2019

Jul 12, 2023

BUY
$11.42 - $22.19 $136,880 - $265,969
11,986 New
11,986 $248,000
Q3 2019

Jul 12, 2023

BUY
$14.74 - $22.28 $176,673 - $267,048
11,986 New
11,986 $216,000
Q3 2019

Mar 22, 2023

BUY
$14.74 - $22.28 $52,415 - $79,227
3,556 Added 42.18%
11,986 $216,000
Q3 2019

Nov 14, 2019

BUY
$14.74 - $22.28 $52,415 - $79,227
3,556 Added 42.18%
11,986 $217,000
Q2 2019

Jul 12, 2023

BUY
$18.35 - $30.34 $219,943 - $363,655
11,986 New
11,986 $234,000
Q1 2019

Jul 13, 2023

BUY
$19.76 - $29.57 $166,576 - $249,275
8,430 New
8,430 $233,000
Q4 2018

Jul 13, 2023

BUY
$18.39 - $26.3 $155,027 - $221,709
8,430 New
8,430 $188,000
Q4 2018

Mar 22, 2023

BUY
$18.39 - $26.3 $155,027 - $221,709
8,430 New
8,430 $188,000
Q4 2018

Feb 14, 2019

BUY
$18.39 - $26.3 $155,027 - $221,709
8,430 New
8,430 $188,000

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.